BioSpace News Archive

DaVita Inc. announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 14, 2019, at 9:00 a.m. Eastern Time.

Sirnaomics, Inc. today announced that the management will present and conduct face-to-face meetings at the 2019 BIO CEO & Investor Conference, to be held in New York, NY on February 11-12.

ADVANZ PHARMA Corp. today commented on the issuance by the UK Competition and Markets Authority (the “CMA”) of a Supplemental Statement of Objections (“SSO”) to the Company and the former owners of the Company’s International segment, Hg Capital and Cinven, in relation to the pricing of Liothyronine in the United Kingdom between January 2009 and July 2017.

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure

Rehabilitation hospital to begin serving patients in Coralville in 2020

Volpara Solutions, Inc. recently announced that it has received FDA 510(k) clearance for technologies used in the Volpara®Density™ clinical application, the benchmark in breast density assessment

Genentech, a member of the Roche Group, announced the decision to discontinue CREAD 1 and CREAD 2 Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with early sporadic Alzheimer’s disease.

Peroxfarma, the company behind the Epaplus line of nutritional supplements, wants to give everyone an “extra dose” of health.

BioInvent is currently investigating this combination in Phase I/IIa study

Series celebrates seventh consecutive year providing a benchmark for payment technology & adoption in industries including ARM, Financial Services and Healthcare